Other
Actavis plans name change to Allergan
Drugmaker Actavis is planning to change its name as it draws closer to finishing another big deal, the $66 billion purchase of Botox maker Allergan that it announced last fall.
Feb 18, 2015
0
2
News tagged with allergan
Other
US family gets $6.75 million in Botox case
A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer won a $6.75 million verdict from a federal jury on Thursday.
Nov 20, 2014
0
0
Other
Actavis to spend $66 billion on Allergan
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.
Nov 17, 2014
0
0
Other
Allergan deal inches forward with court's decision
In a win for Valeant and Pershing Square, a federal judge has decided that they can vote in takeover target Allergan's upcoming shareholder meeting.
Nov 4, 2014
0
0
Other
Valeant: We'll bump Allergan offer to $200 a share
The Canadian drugmaker Valeant said it would be willing to raise its takeover bid for Allergan by almost 12 percent, which would mean $200 or more per share for the maker of Botox.
Oct 27, 2014
0
0
Other
Valeant pitches potential eye drug, research focus
Valeant Pharmaceuticals is drawing attention to a potential glaucoma treatment and its focus on product development, as the Canadian drugmaker continues to build its case to investors for a takeover of Botox-maker Allergan.
Sep 25, 2014
0
0
Other
Valeant Pharma expects 3Q revenue to top forecasts
Shares of Valeant Pharmaceuticals International Inc. climbed Wednesday after the Canadian drugmaker said it expects market share gains in most of its businesses and that its third-quarter revenue will top forecasts.
Sep 24, 2014
0
0
Other
Allergan agrees to move forward with meeting
Allergan and Pershing Square have agreed on at least one step toward settling a fight over the makeup of the Botox-maker's board.
Sep 16, 2014
0
0
Other
Allergan sues Valeant, claims fraud in buy attempt (Update)
Botox and eye-drug maker Allergan is suing a Canadian drugmaker and a hedge fund over their hostile takeover attempt, alleging insider trading and other fraud before their plan became public.
Aug 1, 2014
0
0
Other
Allergan to cut 1,500 employees in restructuring (Update)
Botox maker Allergan will cut about 13 percent of its workforce as part of a push to become more efficient while it fights a hostile takeover bid from Valeant Pharmaceuticals.
Jul 21, 2014
0
0
